Report - BGB-283, a Novel RAF Kinase and EGFR Inhibitor, Displays ... · RAF kinase and EGFR inhibitor with therapeutic potential in targeting oncogenic BRAF in human colorectal carcinoma.

Please pass captcha verification before submit form